Receptor tyrosine kinase AXL has been reported to be overexpressed in a variety of human cancers (e.g., lung cancer, breast cancer, colon cancer, melanoma, and pancreatic cancer) and often correlates with a poor prognosis 7, 19. This evidence concerns the gene AXL and melanoma.